selinexor,Bortezomib,Dexamethasone
karyopharm therapeutics,menarini,SPDR S&P Biotech,iShares Biotechnology
['selinexor', 'xpovio', 'multiple myeloma', 'menarini', '$xbi', '$ibb']
menarini group presents nexpovio (selinexor) subgroup data from boston trial at european hematology association congress, showcasing clinical promise for relapsed/refractory multiple myeloma. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt